Join us for ‘Redefining Rheumatology: Supporting Emerging Approaches’ – an engaging evening of idea exchange on the next frontier of innovative therapies for rheumatic diseases. Rheumatic and musculoskeletal diseases (RMDs) [….]
Ecolab, JNJ and Several Philadelphia companies in the life sciences industry were recognized as one of America’s Greatest Workplaces 2023.
Johnson & Johnson Innovation Opens Applications for Three Funding Opportunities to Fuel Your Life Science Business By Sarah EllinwoodJune 5, 2023 It’s no secret that the current state of the [….]
Astellas Buys Iveric Bio for $5.9 Billion to Bolster Ophthalmology Portfolio By Mark TerryMay 2, 2023 Tokyo-based Astellas Pharma is buying Parsippany, NJ’s Iveric Bio for $5.9 billion. Iveric Bio [….]
Uvax Bio Preps to Take HIV Vaccine into the Clinic By Mark TerryMay 2, 2023 Uvax Bio, headquartered in Newark, Del., recently published preclinical results in Nature Communications showing the [….]
According to the recent Life Sciences Research Outlook & Cluster Rankings report from JLL, the Greater Philadelphia region has advanced four positions in the Life Sciences Cluster Composition Matrix, which measures how each market stacks up in terms of human and physical capital. The regional improvement was due to increased and steady funding supporting the specialization of cell and gene therapy research being conducted in the area, which comes as no surprise as these therapies continue to become increasingly important options in disease treatment.
The challenge provides financial support and mentorship to selected organizations making a key difference through innovative solutions that seek to reduce the inequities among these communities. The latest J&J Health Equity Innovation Challenge recipients in Philadelphia are eCLOSE Institute, which is inspiring diversity in science through STEM education and job training for students from under-resourced schools; Maternity Care Coalition, an organization focused on reducing infant mortality rates among minority communities through its Perinatal Community Health Worker Program that has trained more than 200 perinatal community health workers; and tech startup Viora Health, which is creating a personalized engagement solution to address social and behavioral determinants for conditions like pre-diabetes, diabetes and obesity, all indications that overwhelmingly impact communities of color.
IndyGeneUS AI and the Blockchain-Secured Genomic Data Marketplace IndyGeneUS AI, which is harnessing the power of data mining and artificial intelligence to expedite the development and manufacturing of targeted therapeutics, [….]
We have been covering the biomanufacturing workforce at length this year because it remains one of the most important topics for companies in today’s near full-employment job market.
Emergent BioSolutions Inc. (NYSE:EBS) today announced that two batches of COVID-19 vaccine manufactured by Emergent BioSolutions at its Baltimore Bayview facility were determined to be suitable for use by the U.S. Food & Drug Administration (FDA) and have been authorized as part of Johnson & Johnson’s Emergency Use Authorization (EUA).
